Altimmune vs Incannex Healthcare
ALT and IXHL side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ALT and IXHL compare
Altimmune is the larger company, worth 15 times as much as Incannex Healthcare ($375M against $24.8M).
Incannex Healthcare scores higher on the StockData Score (7 against 4 for Altimmune), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ALT | IXHL |
|---|---|---|
| Size and price | ||
| Market cap | $375M | $24.8M |
| Share price | $1.93 | $1.98 |
| Change, 1 year | −54.7% | −81.8% |
| Change, 5 years | −81.7% | – |
| Beta (5Y) | 1.10 | 1.96 |
| Employees | 13 | 12 |
| StockData Score | ||
| Total score | 4 | 7 (better) |
| Valuation score | 1 | 1 |
| Growth score | 0 | 0 |
| Performance score | 1 | 1 |
| Health score | 2 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/B | 0.8× | 0.4× (better) |
| FCF yield | −20.4% (better) | −52.0% |
| Growth | ||
| Revenue growth, 5Y average | −65.3% | – |
| Profitability | ||
| Return on equity | −28.9% (better) | −47.8% |
| Return on invested capital | −90.4% | – |
| Financial health | ||
| Debt / equity | 0.07 (better) | 0.00 |
| Interest coverage | −28.3× | – |
| Current ratio | 26.78 | 48.81 (better) |
| Altman Z-score | 2.51 (better) | −0.61 |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Buyback yield | −29.3% (better) | −280% |
| Shareholder yield | −29.3% (better) | −280% |
| Ownership | ||
| Held by institutions | 77.9% | 3.6% |
| Held by insiders | 0.51% | – |
| Insider net buying, 12 months | $370K | – |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 21.8% | – |
Go deeper
- ALT stock overview
- ALT income statement
- ALT valuation and score
- IXHL stock overview
- IXHL income statement
- IXHL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.